SEC Form 4 · accession 0001179110-18-002536

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Stephen R Fussell

Officer — Executive Vice President

Period of report

Feb 16, 2018

Accepted (ET)

Feb 21, 2018 · 7:23 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common shares without par value^F1	Feb 16, 2018	A	44,909	$0.00	A	184,884	D
Common shares without par value	Feb 20, 2018	M	104,642	$38.40	A	289,526	D
Common shares without par value	Feb 20, 2018	S	1,100	$59.47	D	288,426	D
Common shares without par value	Feb 20, 2018	S	300	$59.48	D	288,126	D
Common shares without par value	Feb 20, 2018	S	1,419	$59.49	D	286,707	D
Common shares without par value	Feb 20, 2018	S	441	$59.495	D	286,266	D
Common shares without par value	Feb 20, 2018	S	1,200	$59.50	D	285,066	D
Common shares without par value	Feb 20, 2018	S	1,172	$59.51	D	283,894	D
Common shares without par value	Feb 20, 2018	S	200	$59.515	D	283,694	D
Common shares without par value	Feb 20, 2018	S	728	$59.52	D	282,966	D
Common shares without par value	Feb 20, 2018	S	989	$59.53	D	281,977	D
Common shares without par value	Feb 20, 2018	S	226	$59.54	D	281,751	D
Common shares without par value	Feb 20, 2018	S	574	$59.545	D	281,177	D
Common shares without par value	Feb 20, 2018	S	180	$59.56	D	280,997	D
Common shares without par value	Feb 20, 2018	S	500	$59.58	D	280,497	D
Common shares without par value	Feb 20, 2018	S	500	$59.585	D	279,997	D
Common shares without par value	Feb 20, 2018	S	500	$59.59	D	279,497	D
Common shares without par value	Feb 20, 2018	S	100	$59.595	D	279,397	D
Common shares without par value	Feb 20, 2018	S	22,500	$59.60	D	256,897	D
Common shares without par value	Feb 20, 2018	S	1,600	$59.63	D	255,297	D
Common shares without par value	Feb 20, 2018	S	500	$59.635	D	254,797	D
Common shares without par value	Feb 20, 2018	S	1,700	$59.64	D	253,097	D
Common shares without par value	Feb 20, 2018	S	600	$59.645	D	252,497	D
Common shares without par value	Feb 20, 2018	S	4,794	$59.65	D	247,703	D
Common shares without par value	Feb 20, 2018	S	3,200	$59.655	D	244,503	D
Common shares without par value	Feb 20, 2018	S	10	$59.6575	D	244,493	D
Common shares without par value	Feb 20, 2018	S	8,206	$59.66	D	236,287	D
Common shares without par value	Feb 20, 2018	S	2,985	$59.665	D	233,302	D
Common shares without par value	Feb 20, 2018	S	77	$59.668	D	233,225	D
Common shares without par value	Feb 20, 2018	S	100	$59.669	D	233,125	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F2	$59.94	Feb 16, 2018	A	246,963	A	Feb 16, 2019	Feb 15, 2028	Common shares	246,963	246,963	D
Option (right to buy)^F3	$38.40	Feb 20, 2018	M	104,642	D	Feb 19, 2018	Feb 18, 2026	Common shares	104,642	104,642	D

Explanation of responses

F1These shares represent performance vested restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 82,321 on 02/16/2019, 82,321 on 02/16/2020, and 82,321 on 02/16/2021.
F3Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks

The option exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Form 1 of 3.